Where I see patients (1)
My reviews
Selected research
-
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN.
Blood cancer journal
-
Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma.
Blood advances
-
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Clinical trials
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421
4.8